Cargando…

Genetic contribution to multiple sclerosis risk among Ashkenazi Jews

BACKGROUND: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, with a strong genetic component. Over 100 genetic loci have been implicated in susceptibility to MS in European populations, the most prominent being the 15:01 allele of the HLA-DRB1 gene. The prevalence of M...

Descripción completa

Detalles Bibliográficos
Autores principales: Khankhanian, Pouya, Matsushita, Takuya, Madireddy, Lohith, Lizée, Antoine, Din, Lennox, Moré, Jayaji M, Gourraud, Pierre-Antoine, Hauser, Stephen L, Baranzini, Sergio E, Oksenberg, Jorge R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557862/
https://www.ncbi.nlm.nih.gov/pubmed/26212423
http://dx.doi.org/10.1186/s12881-015-0201-2
_version_ 1782388532164165632
author Khankhanian, Pouya
Matsushita, Takuya
Madireddy, Lohith
Lizée, Antoine
Din, Lennox
Moré, Jayaji M
Gourraud, Pierre-Antoine
Hauser, Stephen L
Baranzini, Sergio E
Oksenberg, Jorge R
author_facet Khankhanian, Pouya
Matsushita, Takuya
Madireddy, Lohith
Lizée, Antoine
Din, Lennox
Moré, Jayaji M
Gourraud, Pierre-Antoine
Hauser, Stephen L
Baranzini, Sergio E
Oksenberg, Jorge R
author_sort Khankhanian, Pouya
collection PubMed
description BACKGROUND: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, with a strong genetic component. Over 100 genetic loci have been implicated in susceptibility to MS in European populations, the most prominent being the 15:01 allele of the HLA-DRB1 gene. The prevalence of MS is high in European populations including those of Ashkenazi origin, and low in African and Asian populations including those of Jewish origin. METHODS: Here we identified and extracted a total of 213 Ashkenazi MS cases and 546 ethnically matched healthy control individuals from two previous genome-wide case-control association analyses, and 72 trios (affected proband and two unaffected parents) from a previous genome-wide transmission disequilibrium association study, using genetic data to define Ashkenazi. We compared the pattern of genetic risk between Ashkenazi and non-Ashkenazi Europeans. We also sought to identify novel Ashkenazi-specific risk loci by performing association tests on the subset of Ashkenazi cases, controls, probands, and parents from each study. RESULTS: The HLA-DRB1*15:01 allele and the non-HLA risk alleles were present at relatively low frequencies among Ashkenazi and explained a smaller fraction of the population-level risk when compared to non-Ashkenazi Europeans. Alternative HLA susceptibility alleles were identified in an Ashkenazi-only association study, including HLA-A*68:02 and one or both genes in the HLA-B*38:01-HLA-C*12:03 haplotype. The genome-wide screen in Ashkenazi did not reveal any loci associated with MS risk. CONCLUSION: These results suggest that genetic susceptibility to MS in Ashkenazi Jews has not been as well established as that of non-Ashkenazi Europeans. This implies value in studying large well-characterized Ashkenazi populations to accelerate gene discovery in complex genetic diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-015-0201-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4557862
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45578622015-09-03 Genetic contribution to multiple sclerosis risk among Ashkenazi Jews Khankhanian, Pouya Matsushita, Takuya Madireddy, Lohith Lizée, Antoine Din, Lennox Moré, Jayaji M Gourraud, Pierre-Antoine Hauser, Stephen L Baranzini, Sergio E Oksenberg, Jorge R BMC Med Genet Research Article BACKGROUND: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, with a strong genetic component. Over 100 genetic loci have been implicated in susceptibility to MS in European populations, the most prominent being the 15:01 allele of the HLA-DRB1 gene. The prevalence of MS is high in European populations including those of Ashkenazi origin, and low in African and Asian populations including those of Jewish origin. METHODS: Here we identified and extracted a total of 213 Ashkenazi MS cases and 546 ethnically matched healthy control individuals from two previous genome-wide case-control association analyses, and 72 trios (affected proband and two unaffected parents) from a previous genome-wide transmission disequilibrium association study, using genetic data to define Ashkenazi. We compared the pattern of genetic risk between Ashkenazi and non-Ashkenazi Europeans. We also sought to identify novel Ashkenazi-specific risk loci by performing association tests on the subset of Ashkenazi cases, controls, probands, and parents from each study. RESULTS: The HLA-DRB1*15:01 allele and the non-HLA risk alleles were present at relatively low frequencies among Ashkenazi and explained a smaller fraction of the population-level risk when compared to non-Ashkenazi Europeans. Alternative HLA susceptibility alleles were identified in an Ashkenazi-only association study, including HLA-A*68:02 and one or both genes in the HLA-B*38:01-HLA-C*12:03 haplotype. The genome-wide screen in Ashkenazi did not reveal any loci associated with MS risk. CONCLUSION: These results suggest that genetic susceptibility to MS in Ashkenazi Jews has not been as well established as that of non-Ashkenazi Europeans. This implies value in studying large well-characterized Ashkenazi populations to accelerate gene discovery in complex genetic diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-015-0201-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-28 /pmc/articles/PMC4557862/ /pubmed/26212423 http://dx.doi.org/10.1186/s12881-015-0201-2 Text en © Khankhanian et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Khankhanian, Pouya
Matsushita, Takuya
Madireddy, Lohith
Lizée, Antoine
Din, Lennox
Moré, Jayaji M
Gourraud, Pierre-Antoine
Hauser, Stephen L
Baranzini, Sergio E
Oksenberg, Jorge R
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
title Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
title_full Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
title_fullStr Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
title_full_unstemmed Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
title_short Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
title_sort genetic contribution to multiple sclerosis risk among ashkenazi jews
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557862/
https://www.ncbi.nlm.nih.gov/pubmed/26212423
http://dx.doi.org/10.1186/s12881-015-0201-2
work_keys_str_mv AT khankhanianpouya geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT matsushitatakuya geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT madireddylohith geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT lizeeantoine geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT dinlennox geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT morejayajim geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT gourraudpierreantoine geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT hauserstephenl geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT baranzinisergioe geneticcontributiontomultiplesclerosisriskamongashkenazijews
AT oksenbergjorger geneticcontributiontomultiplesclerosisriskamongashkenazijews